Orchid Pharma reports consolidated net loss of Rs 12.61 crore in the December 2025 quarter
Sales decline 4.63% to Rs 207.27 crore
Net loss of Orchid Pharma reported to Rs 12.61 crore in the quarter ended December 2025 as against net profit of Rs 20.78 crore during the previous quarter ended December 2024. Sales declined 4.63% to Rs 207.27 crore in the quarter ended December 2025 as against Rs 217.34 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales207.27217.34 -5 OPM %0.7512.13 -PBDT3.9931.06 -87 PBT-5.0422.45 PL NP-12.6120.78 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content